[1]
Wang, L. et al. 2016. Retraction: Monotherapy with meropenem versus combination therapy of ceftazidime plus amikacin for empirical treatment of cancer patients with Febrile Neutropenic (FN): systematic review and meta-analysis. European Journal of Oncology and Environmental Health. 21, 3 (Dec. 2016).